BackMolecular Data Overview

Molecular Data Receivables

Latest receivables for MKD: $93M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$92.77M

Peer trimmed avg / median

Loading

Molecular Data Receivables History

Loading

Molecular Data vs. peers: Receivables Comparison

Loading

Molecular Data Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Molecular Data (MKD) FAQ

As of the most recent data (September 2021), MKD shows a receivables of $93M. Scroll down for historical charts and peer comparison views.

Tracking MKD's receivables over time shows whether Molecular Data is scaling, shrinking, or reshaping that part of the business. The current reading is $93M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Molecular Data's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $93M) with ownership activity and broader fundamentals.

Molecular Data's receivables is $93M; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.